Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty

BMC Urology

Volumn 17, Issue 1, 2017, Pages 1-8

  Mader, Emily M ^a   Li, Hsin H ^a,b   Lyons, Kathleen D ^c   Morley, Christopher P ^a,b   Formica, Margaret K ^b   Perrapato, Scott D ^d   Irwin, Brian H ^d   Seigne, John D ^c   Hyams, Elias S ^c   Mosher, Terry ^c   Hegel, Mark T ^c,e   Stewart, Telisa M ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e NORRIS COTTON CANCER CENTER   (United States)

Author keywords

Active surveillance; Coping behavior; Prostatic neoplasm; Qualitative research

Indexed keywords

ACTIVE SURVEILLANCE; AGED; ANXIETY; ARTICLE; CANCER RISK; CLINICAL ARTICLE; HUMAN; LIFESTYLE MODIFICATION; LOW RISK PATIENT; MALE; MENTAL STRESS; PATIENT DECISION MAKING; PATIENT MONITORING; PROSTATE CANCER; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW; SOCIAL NETWORK; SOCIAL SUPPORT; STRESS MANAGEMENT; THEMATIC ANALYSIS; TREATMENT PLANNING; COMPLICATION; COPING BEHAVIOR; ETIOLOGY; PATIENT PREFERENCE; PROSTATE TUMOR; PSYCHOLOGY; RISK ASSESSMENT; UNCERTAINTY; WATCHFUL WAITING;

ADAPTATION, PSYCHOLOGICAL; AGED; HUMANS; MALE; PATIENT PREFERENCE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; STRESS, PSYCHOLOGICAL; UNCERTAINTY; WATCHFUL WAITING;

EID: 85018419812     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/s12894-017-0225-3     Document Type: Article

References (33)

1. Filson C, Marks L, Litwin M. Expectant management for men with early stage prostate cancer. CA Cancer J Clin. 2015;65:264-82.
2. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, et al. Prostate cancer, version 2.2014. J Natl Compr Canc Netw. 2014;12:686-718.
3. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Prostate cancer: guideline for the management of clinically localized prostate cancer 2007 update. J Urol. 2007;177(6):2106-31.
4. Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304:2373-80.
5. American Cancer Society. Expectant management, watchful waiting, and active surveillance for prostate cancer [Internet]. Prostate Cancer. 2015 [cited 2015 May 13]. Available from: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-treating-watchful-waiting.
6. Bellardita L, Rancati T, Alvisi MF, Villani D, Magnani T, Marenghi C, et al. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol. 2013;64:30-6.
7. Kazer MW, Psutka SP, Latini DM, Bailey DE. Psychosocial aspects of active surveillance. Curr Opin Urol. 2013;23:273-7.
8. Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, et al. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016;117(3):469-77.
9. Yanez B, Bustillo NE, Antoni MH, Lechner SC, Dahn J, Kava B, et al. The importance of perceived stress management skills for patients with prostate cancer in active surveillance. J Behav Med [Internet]. Springer US; 2015 [cited 2016 Aug 26];38:214-23. Available from: http://link.springer.com/10.1007/s10865-014-9594-1.
10. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16:143-63.
11. Leventhal H. Findings and theory in the study of fear communications. Adv Exp Soc Psychol. 1970;5:119-86.
12. Lyons KD, Li HH, Mader EM, Stewart TM, Morley CP, Formica MK, et al. Cognitive and affective representations of active surveillance as a treatment option for low-risk prostate cancer. Am J Mens Health [Internet]. 2016 [cited 2016 Aug 26]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/27365211.
13. Meadows LM, Verdi AJ, Crabtree BF. Keeping up appearances: using qualitative research to enhance knowledge of dental practice. J Dent Educ. 2003;67:981-90.
14. Borkan J. Immersion/Crystallization. In: Crabtree BF, Miller WL, editors. Doing Qual. Res. 2nd ed. Thousand Oaks: SAGE Publications; 1999. p. 179-94.
15. Penson DF. Factors influencing patients’ acceptance and adherence to active surveillance. J Natl Cancer Inst Monogr. 2012;2012:207-12.
16. Davison BJ, Goldenberg SL. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int [Internet]. 2011 [cited 2015 Apr 2];108:1787-93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21507187.
17. Gorin MA, Soloway CT, Eldefrawy A, Soloway MS. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology. 2011;77:588-91.
18. van den Bergh RCN, van Vugt HA, Korfage IJ, Steyerberg EW, Roobol MJ, Schröder FH, et al. Disease insight and treatment perception of men on active surveillance for early prostate cancer. BJU Int. 2010;105:322-8.
19. Volk RJ, McFall SL, Cantor SB, Byrd TL, Le Y-CL, Kuban DA, et al. “It’s not like you just had a heart attack”: decision-making about active surveillance by men with localized prostate cancer. Psychooncology. 2014;23:467-72.
20. Davison BJ, Oliffe JL, Pickles T, Mroz L. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum. 2009;36:89-96.
21. Oliffe JL, Davison BJ, Pickles T, Mroz L. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qual Health Res. 2009;19:432-43.
22. Simpson P. Does active surveillance lead to anxiety and stress? Br J Nurs. 2014;23 Suppl 1:S4-12.
23. Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R. Is “watchful waiting” a real choice for men with prostate cancer? A qualitative study. BJU Int. 2002;90:257-64.
24. Pickles T, Ruether D, Weir L, Carlson L, Jakulj F, SCRN Communication Team. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007;100:544-51.
25. Rossen S, Hansen-Nord NS, Kayser L, Borre M, Larsen RG, Trichopoulou A, et al. The impact of husbands’ prostate cancer diagnosis and participation in a behavioral lifestyle intervention on spouses’ lives and relationships with their partners. Cancer Nurs. 2015. doi:10.1097/NCC.0000000000000259.
26. Victorson D, Hankin V, Burns J, Weiland R, Maletich C, Sufrin N, et al. Feasibility, acceptability and preliminary psychological benefits of mindfulness meditation training in a sample of men diagnosed with prostate cancer on active surveillance: results from a randomized controlled pilot trial. Psychooncology. 2016. doi:10.1002/pon.4135.
27. Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, et al. A qualitative analysis of interviews of men with early stage prostate cancer: the Prostate Cancer Lifestyle Trial. Cancer Nurs. 2005;28:99-107.
28. Hawes SM, Malcarne VL, Ko CM, Sadler GR, Banthia R, Sherman SA, et al. Identifying problems faced by spouses and partners of patients with prostate cancer. Oncol Nurs Forum. 2006;33:807-14.
29. Voerman B, Visser A, Fischer M, Garssen B, VanAndel G, Bensing J. Determinants of participation in social support groups for prostate cancer patients. Psychooncology. 2007;16:1092-9.
30. Maliski SL, Heilemann MV, McCorkle R. From “death sentence” to “good cancer”: couples’ transformation of a prostate cancer diagnosis. Nurs Res. 2002;51:391-7.
31. Bottorff JL, Oliffe JL, Halpin M, Phillips M, McLean G, Mroz L. Women and prostate cancer support groups: the gender connect? Soc Sci Med. 2008;66:1217-27.
32. Traeger L, Penedo FJ, Gonzalez JS, Dahn JR, Lechner SC, Schneiderman N, et al. Illness perceptions and emotional well-being in men treated for localized prostate cancer. J Psychosom Res. 2009;67:389-97.
33. Underwood W, Orom H, Poch M, West BT, Lantz PM, Chang SS, et al. Multiple physician recommendations for prostate cancer treatment: a Pandora’s box for patients? Can J Urol. 2010;17:5346-54.